RCS - Skin Logistics - Skin Logistics launches £1.2m Series A fundraising

Procter & Gamble CoAnnouncement

24/04/2023 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230424:nRSX2553Xa&default-theme=true

RNS Number : 2553X  Skin Logistics  24 April 2023

Skin Logistics launches £1.2m Series A fundraising
The move comes as it launches in the US and prepares for a UK rollout

A company in South Wales that has developed a new and innovative range of
skincare products, has launched its Series A fundraising - hot on the heels of
signing lucrative contracts and launching in the US and ahead of a UK rollout.

Skin Logistics from left: Kevin Smith, Founder and CEO; Ceri Stephens, Office
Manager; Jo Matthews, Head of Finance; and Marc Clement, Founder.

Skin Logistics, which produces the Platina™ range of premium, professional
skin therapy products clinically proven to deliver unparalleled results and
designed to complement and enhance the efficacy of high energy light-based
skincare treatments, is seeking to raise £1.2 million from institutional
investors, venture capital or business angels, ideally with experience and
expertise in the professional cosmetic or medical technology space. The
funding round has opened and will close by the end of May.

To date, the company has been funded by its founder shareholders and a loan
from the Development Bank of Wales. However, with ambitious expansion plans in
the pipeline, including a distribution agreement in the US, new contracts in
the Middle East and an official launch to consumers in the UK, it is seeking
new partners to assist on its journey.

The company was established in 2020 by Kevin Smith and Marc Clement, two
entrepreneurs with a proven track record in the medical technology space, and
three renowned specialists: Professor Peter Bjerring, one of Europe's most
eminent dermatologists; Dr Dianne Quibell, a leading cosmetic doctor based in
metro Boston, USA; and Panagis Voutsinas, a chemist and successful
entrepreneur in the cosmetic, food and pharmaceutical sectors.

The team started the venture with the aim of developing a range of skincare
products that were genuinely effective for all users but would also complement
and enhance the effects of the growing range of high-energy devices used for
skincare. A key breakthrough was the development of a mix of active
ingredients able to penetrate the epidermal barrier. Additionally, the unique
partnership created by this team has attracted global companies that require
companion topicals for their devices.

Smith and Clement have strong track records in this space. They were both
founders CyDen, a specialist in the design and manufacture of IPL (intense
pulsed light) hair removal products for use at home. That company has now sold
more than 2.5 million devices in 50 territories globally in partnership with
P&G and under its own brand. Since that venture both have also enjoyed
success launching and investing in other businesses.

Professor Peter Bjerring is the former Medical Director and Head of the
Department of Dermatology at the Molholm Hospital, Denmark. Since 2019 he has
served as the Clinical Professor at the Department of Dermatology, Aalborg
University Hospital. He has published more than 250 scientific papers and
contributed with more than 500 lectures at international congresses and
scientific meetings. He is also the Past President of the European Society for
Lasers in Dermatology and Past Vice President of the European Society for
Laser Aesthetic Surgery.

Dianne Quibell is a world-renowned cosmetic laser surgeon, and aesthetic
physician. She is the Vice President of the American Board of Laser Surgery
(since 2008), and Fellow of The American Society for Laser Medicine and
Surgery. Quibell has lectured nationally and internationally since 2001 and
was also Assistant Clinical Professor of Medicine at Harvard Medical School.
She privately trains clinicians in aesthetic laser procedures, BOTOX®,
fillers, and laser assisted lipolysis.

Kevin Smith, CEO of Skin Logistics, said:

"It is exciting to be embarking on a new journey in the full knowledge that
the skin therapy system we have developed will make a real and tangible
difference to our customers - unlike many of the premium products available
off the shelf or through professional channels. The team we have pulled
together is world class in their knowledge of both Dermatology and Laser
Surgery also offering us a global perspective on the markets we wish to
target. We uniquely also have the skills to conceptualise, develop, clinically
evaluate, manufacture and deliver products for white label partners.

"We have already made several breakthroughs, secured some lucrative contracts
and have momentum. This Series A round of funding will allow us to take the
company to the next level in our target markets of choice."

 

-     ENDS   -

 

PRESS CONTACT:

 

Seren Global Media 01792 293333 Wyn.Jenkins@serenglobalmedia.com
https://www.serenglobalmedia.com/

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFLFELSLISFIV